9371
|
|
|
Pyrimidinergic receptor P2Y6 |
P2Y6 |
|
9372
|
|
|
Prolyl 3-hydroxylase 1 |
GROS1, LEPRE1, OI8 |
|
9373
|
|
|
Prolyl 3-hydroxylase 2 |
LEPREL1, MCVD, MLAT4 |
|
9374
|
|
|
Prolyl 3-hydroxylase 3 |
GRCB, HSU47926, LEPREL2 |
|
9375
|
|
|
P3R3URF-PIK3R3 readthrough |
LOC110117498-PIK3R3 |
|
9376
|
|
|
Prolyl 4-hydroxylase subunit alpha 1 |
P4HA |
|
9377
|
|
|
Prolyl 4-hydroxylase subunit alpha 2 |
MYP25, lncRNA-PE |
Asthma, Eczema, Basal cell carcinoma, Cardiovascular disease, Coronary artery disease, Crohn disease, Giant cell arteritis, Gout, Inflammatory bowel disease, Myopia, Retinitis pigmentosa, Ulcerative colitis, Vasculitis |
9378
|
|
|
Prolyl 4-hydroxylase subunit alpha 3 |
- |
|
9379
|
|
|
Prolyl 4-hydroxylase subunit beta |
CLCRP1, DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PHDB, PO4DB, PO4HB, PROHB |
Bone fragility with contractures, arterial rupture, and deafness, Cole-carpenter syndrome, Desbuquois syndrome, Heart disease, Myocardial ischemia, Osteogenesis imperfecta, Osteoporosis, Osteoporosis-pseudoglioma syndrome, Prostatic neoplasms, Spinocerebellar ataxia |
9380
|
|
|
Prolyl 4-hydroxylase, transmembrane |
EGLN4, HIDEA, HIFPH4, P4H-TM, PH-4, PH4, PHD4 |
|